Back to filter
Original filing (PDF)20250930161903NAL0005587059001
OCULAR SCIENCE, INC.
Form 5500-SF
FILING_RECEIVED
OCULAR SCIENCE & AFFILIATES 401(K) PLAN
401(k) retirement plan
Signals · 1
No auditor on file
Active participants
121
Accounts w/ balance
81
Plan assets (EOY)
$2.8M
Net assets (EOY)
$2.8M
Plan health score (directional)
74
/ 100
Grade B
Above-average plan
Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.
Compliance & disclosures
60
Concentration risk
75
Total plan cost
75
Vendor stack
100
Participation health
80
Knocking points off
- No independent qualified public accountant (IQPA) named.
- 67% balance-to-active ratio — below typical for a healthy 401(k).
Helping the score
- Concentration not scored — Schedule of Assets PDF not yet parsed for this plan.
- No Schedule C compensation disclosed — likely a small plan or unbundled.
Decision-maker contacts
CFO / Head of HR / Benefits Manager — verified email + LinkedIn for OCULAR SCIENCE, INC..
Plan sponsor
Name
OCULAR SCIENCE, INC.
EIN
47-4722550
Address
118 CENTER STREET · EL SEGUNDO, CA · 90245
Phone
(616) 206-7375
Industry
Manufacturingsee all
Plan administrator
Same as plan sponsor.
Plan characteristics
Plan number
001
Plan year
2024
Plan year begin
2024-01-01
Tax period
2024-12-31
Filed
2025-09-30
Pension benefit codes
2A · Age/service weighted or new comparability
2E · Profit-sharing
2F · ERISA section 404(c)
2G · Total participant-directed accounts
2J · 401(k) feature
2K · 401(m) arrangement
3D · Pre-approved plan (master / prototype / VS)
3H · Sponsor in controlled / affiliated group
Audit & trust (Schedule H)
Auditor
—
Trustee / custodian
—
Trustee phone
—
Small plan (5500-SF) — Schedule H data not available.
Service providers (Schedule C)
Small plans don't disclose service providersRelated plans
Similar-size Manufacturing plans
THERATECHNOLOGIES U.S., INC.
THERATECHNOLOGIES U.S., INC. 401(K) PLAN
$2.8M · 41 participants
GOODWIN BIOTECHNOLOGY, INCORPORATED
GOODWIN BIOTECHNOLOGY 401(K) PLAN
$2.8M · 62 participants
SUMMIT THERAPEUTICS INC.
SUMMIT THERAPEUTICS INC. 401(K) PLAN
$2.8M · 40 participants
TAIMED BIOLOGICS USA
TAIMED BIOLOGICS USA 401K
$2.8M · 3 participants
SAFE N SIMPLE, L.L.C.
SAFE N SIMPLE, L.L.C. CASH BALANCE PLAN
$2.8M · 14 participants
DELIX THERAPEUTICS INC
DELIX THERAPEUTICS INC 401(K) PLAN
$2.7M · 23 participants
Large plans in California
BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
EQUITY INDEX FUND
$215.1B
BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
EQUITY INDEX FUND E
$190.9B
BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
EQUITY INDEX FUND F
$188.1B
BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
RUSSELL 1000 INDEX FUND
$187.7B
BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
CASH EQUIVALENT FUND II
$125.0B
BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
BLACKROCK MSCI ACWI EX-US IMI INDEX FUND E
$88.3B